3D printed chitosan/polycaprolactone scaffold for lung tissue engineering: hope to be useful for COVID-19 studies
Farnoush Sadat Rezaei, Ayeh Khorshidian, Farzaneh Mahmoudi Beram, Atefeh Derakhshani, Javad Esmaeili, Aboulfazl Barati
Abstract
. To sum up, scaffold 3 (chitosan/polycaprolactone ratio: 4 : 1) revealed better activity for MRC-5 cell culture. Thereby, this scaffold can be a good candidate for lung tissue engineering and may be applicable for more studies on the COVID-19 virus.
Topics & Concepts
PolycaprolactoneScaffoldChitosanCoronavirus disease 2019 (COVID-19)Tissue engineeringLungSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Biomedical engineeringChemistryMaterials scienceNanotechnologyChemical engineeringEngineeringMedicineComposite materialInternal medicinePolymerDiseaseInfectious disease (medical specialty)3D Printing in Biomedical ResearchBone Tissue Engineering MaterialsAdditive Manufacturing and 3D Printing Technologies